Results 101 to 110 of about 200,309 (203)

Design, Synthesis, and Biological Characterization of Macromolecular Ester Prodrugs of a Selective Cyclooxygenase-2 Inhibitor. [PDF]

ChemMedChem
Saletti M, Paolino M, Venditti J, Giuliani G, Rossi A, D'Avino D, Perna S, Varfaj I, Sardella R, Macchiarulo A, Maramai S, Lamponi S, Cappelli A, Anzini M.   +13 more
europepmc   +1 more source

Author Correction: Inhibition of cyclooxygenase-2 activity in subchondral bone modifies a subtype of osteoarthritis. [PDF]

Bone Res
Tu M, Yang M, Yu N, Zhen G, Wan M, Liu W, Ji B, Ma H, Guo Q, Tong P, Cao L, Luo X, Cao X.   +12 more
europepmc   +1 more source

Protein kinase a regulates cyclooxygenase-2 expression through the RNA-binding proteins HuR and TTP. [PDF]

J Biol Chem
Adame-Garcia SR, Hoang TS, Tien Vo PT, Burghi V, Cervantes-Villagrana RD, Orduña-Castillo LB, Ramms DJ, Trejo J, Gutkind JS.   +8 more
europepmc   +1 more source

Cyclooxygenase-2 expression in advanced oral squamous cell carcinoma: a biomarker of poor prognosis. [PDF]

BMC Oral Health
Chen X, Ouyang Q, Fan R, Luo L, Mai H.
europepmc   +1 more source

Aberrantly activated Cox-2 and Wnt signaling interact to maintain cancer stem cells in glioblastoma [PDF]

, 2017
Das, Sunit, Dhand, Karan, Guan, Jennifer, Gunter, Simon, Kim, Albert, Li, Chris, Morshead, Cindi, Ng, Sheena, Nusrat, Labeeba, Wu, Megan   +9 more
core   +3 more sources

Temporal Trend in Selective Cyclooxygenase-2 Inhibitors Sales in Brazilian Drugstores. [PDF]

Pharmacoepidemiol Drug Saf
Biase TMMA, Silva MT, Lopes L, Galvao TF.   +3 more
europepmc   +1 more source

PTUPB, a soluble epoxide hydrolase/cyclooxygenase‑2 dual inhibitor, reduces endothelial‑to‑mesenchymal transition and improves doxorubicin‑induced vascular and cardiac toxicity. [PDF]

Mol Med Rep
Dhulkifle H, Therachiyil L, Hasan MH, Younis SM, Al-Shar'i NA, Yalcin HC, Maayah ZH.   +6 more
europepmc   +1 more source

Cyclooxygenase-1 (COX-1); cyclooxygenase-2 (COX-2) [PDF]

Science-Business eXchange, 2008
openaire   +1 more source

Decoding intratumoral cyclooxygenase-2 signaling through multi-omics: insights from esophageal cancer and beyond. [PDF]

Clin Exp Med
Zhuang XY, Xu DM, Chen JN, Huang XY, Wu SP, Zhang YF, He XH.   +6 more
europepmc   +1 more source

In-silico studies, synthesis, and pharmacological screening of novel multitarget diphenylpyrazole scaffold as EGFR/BRAF and cyclooxygenase-2 inhibitors. [PDF]

Sci Rep
Abdelgawad MA, Bukhari SNA, Elkomy MH, Elmowafy M, Mostafa EM, Musa A, Ahmad W, Abdel-Bakky MS, Farouk A, Elshemy HAH, El-Din AGS.   +10 more
europepmc   +1 more source